Breaking News, Financial News

3Q Financial Report: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 3Q Revenues: $44.2 million (flat) 3Q Earnings: $1.4 million (-68%) YTD Revenues: $133.2 million (-8%) YTD Earnings: $2.9 million (-83%) Comments: Total contract revenue for the quarter was $37.9 million, up 20%. Contract revenue for discovery services was $10.0 million, up 61%. Contract revenue from development and small scale manufacturing in the quarter was $9.6 million, up 45%. Large scale manufacturing revenues were $18.2 million, down 2%. Results for the quarter and...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters